Amdocs insider plans sale of 12,780 shares

Amdocs Ltd. reporting person Tamar Rapaport Dagim filed to potentially sell 12,780 Ordinary Shares of Amdocs Ltd. through Oppenheimer & Co. Inc., with an aggregate market value of $678,618.00, currently expected on July 28, 2026 on Nasdaq.

Rhea-AI Filing Summary

Amdocs Ltd. reporting person Tamar Rapaport Dagim filed to potentially sell 12,780 Ordinary Shares of Amdocs Ltd. through Oppenheimer & Co. Inc., with an aggregate market value of $678,618.00, currently expected on July 28, 2026 on Nasdaq.

The shares were originally issued upon vesting of RSUs on November 11, 2023 for no cash consideration. The filing also notes that during the past three months, 107,577 Ordinary Shares were sold on July 23, 2026 for aggregate proceeds of $5,436,262.88.

Key Figures

Shares planned for sale: 12,780 shares Aggregate market value: $678,618.00 Planned sale date: 07/28/2026 +3 more

6 metrics

Shares planned for sale 12,780 shares Ordinary Shares of Amdocs Ltd. covered by the notice

Aggregate market value $678,618.00 Value of 12,780 Ordinary Shares to be sold

Planned sale date 07/28/2026 Expected Nasdaq sale date for the 12,780 shares

RSU vesting date 11/11/2023 Date shares were issued upon vesting of RSUs

Recent shares sold 107,577 shares Ordinary Shares sold within past three months

Recent sale proceeds $5,436,262.88 Aggregate proceeds from 107,577-share sale on 07/23/2026

Key Terms

Ordinary Shares, RSUs, No consideration

3 terms

Ordinary Shares financial

"Ordinary Shares | Oppenheimer & Co. Inc. 85 Broad St."

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

RSUs financial

"Shares issued upon vesting of RSUs | AMDOCS LTD"

RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.

No consideration financial

"No consideration, shares issued upon vesting of RSUs"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What share sale is Tamar Rapaport Dagim planning for Amdocs (DOX)?

Tamar Rapaport Dagim plans a potential sale of 12,780 Ordinary Shares of Amdocs Ltd. The shares, valued at $678,618.00, are expected to be sold through Oppenheimer & Co. Inc. on July 28, 2026 on Nasdaq.

How did Tamar Rapaport Dagim acquire the Amdocs (DOX) shares covered by this notice?

The 12,780 Ordinary Shares were issued upon vesting of RSUs on November 11, 2023. The filing states there was no consideration paid for these shares, as they resulted from restricted stock unit vesting.

What recent Amdocs (DOX) share sales by Tamar Rapaport Dagim are disclosed?

The filing discloses that on July 23, 2026, Tamar Rapaport Dagim sold 107,577 Ordinary Shares of Amdocs Ltd. for total proceeds of $5,436,262.88. This transaction is listed as occurring within the past three months.

Which broker is handling Tamar Rapaport Dagim’s planned Amdocs (DOX) share sale?

The planned sale of 12,780 Ordinary Shares of Amdocs Ltd. is to be executed through Oppenheimer & Co. Inc., located at 85 Broad St., New York, NY 10004, with trading expected on Nasdaq.

What type of Amdocs (DOX) security is involved in this planned sale?

The filing involves Ordinary Shares of Amdocs Ltd. A total of 12,780 shares are covered by the prospective sale, with an indicated aggregate market value of $678,618.00 as disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/28/2026 - 02:53 PM Accepted by SEC EDGAR 07/28/2026 - 02:52 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001968313
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	AMDOCS LTD
SEC File Number	001-14840
Address of Issuer	P.O BOX 263, HIRZEL HOUSE, SMITH STREET ST. PETER PORT GUERNSEY 0
Phone	011-44-1481-728444
Name of Person for Whose Account the Securities are To Be Sold	Rapaport-Dagim Tamar
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Former Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary Shares	Oppenheimer & Co. Inc. 85 Broad St. New York NY 10004	12780	678618.00	108448276	07/28/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary Shares	11/11/2023	Shares issued upon vesting of RSUs	AMDOCS LTD			12780	11/11/2023	No consideration, shares issued upon vesting of RSUs

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Tamar Rapaport Dagim P.O BOX 263, HIRZEL HOUSE, SMITH STREET ST. PETER PORT Y7 0	Ordinary Shares	07/23/2026	107577	5436262.88

144: Remarks and Signature

Remarks	The securities are being sold pursuant to a Rule 10b5-1 trading plan adopted on 06/23/2026
Date of Notice	07/28/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/23/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Tamar Rapaport Dagim By: /s/ Liron Avigdor Title: Authorized Signatory, Oppenheimer Israel (pursuant to delegation)
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)